Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McMaster University

$27,000.00

Characterizing circulating and airway eosinophil heterogeneity in severe asthma

EF 2025-26

Résumé
Rationale: Severe asthma affects a small proportion of patients (~5%) but accounts for most asthma-related healthcare costs in Canada. Despite major advances in biologic therapies, up to 50% of patients fail to achieve meaningful clinical benefit, reflecting a critical unmet need and incomplete understanding of disease mechanisms. Eosinophils are central drivers of airway inflammation and tissue remodeling, and our group has demonstrated that airway autoimmunity contributes to severe disease. Emerging evidence supports the concept of eosinophil heterogeneity, whereby functionally distinct subsets arise in response to local tissue signals; however, this has not been systematically evaluated in severe asthma. Hypothesis: The airway microenvironment programs distinct eosinophil immunophenotypes and transcriptional states that generate disease-relevant subsets associated with asthma control, exacerbations, and treatment response. Methods: We will prospectively evaluate patients with severe asthma at stable baseline (V1) and during exacerbation (V2), collecting blood, sputum, and serum/plasma. Healthy controls will be studied at baseline. Aim 1: Define eosinophil responses to clinically relevant triggers in vitro and determine the role of Bruton’s tyrosine kinase (BTK) signaling in eosinophil extracellular trap formation. Aim 2: Integrate high-dimensional immunophenotyping and single-cell transcriptomics of blood and sputum eosinophils to identify pathogenic subsets and relate these to clinical outcomes. Aim 3: Define airway and systemic autoimmune signatures and integrate these with eosinophil states. Impact: This project will identify distinct eosinophil subsets and biomarkers to enable precision medicine in severe asthma and improve understanding of treatment failure.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573076
Name
Ruzic Alexander
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing circulating and airway eosinophil heterogeneity in severe asthma
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Airway Autoimmunity; Airway Microenvironment; Eosinophil Extracellular Traps (Eets); Eosinophil Heterogeneity; Flow Cytometry; Immune Biomarkers; Severe Asthma; Single-Cell Transcriptomics
Abstract
Rationale: Severe asthma affects a small proportion of patients (~5%) but accounts for most asthma-related healthcare costs in Canada. Despite major advances in biologic therapies, up to 50% of patients fail to achieve meaningful clinical benefit, reflecting a critical unmet need and incomplete understanding of disease mechanisms. Eosinophils are central drivers of airway inflammation and tissue remodeling, and our group has demonstrated that airway autoimmunity contributes to severe disease. Emerging evidence supports the concept of eosinophil heterogeneity, whereby functionally distinct subsets arise in response to local tissue signals; however, this has not been systematically evaluated in severe asthma. Hypothesis: The airway microenvironment programs distinct eosinophil immunophenotypes and transcriptional states that generate disease-relevant subsets associated with asthma control, exacerbations, and treatment response. Methods: We will prospectively evaluate patients with severe asthma at stable baseline (V1) and during exacerbation (V2), collecting blood, sputum, and serum/plasma. Healthy controls will be studied at baseline. Aim 1: Define eosinophil responses to clinically relevant triggers in vitro and determine the role of Bruton’s tyrosine kinase (BTK) signaling in eosinophil extracellular trap formation. Aim 2: Integrate high-dimensional immunophenotyping and single-cell transcriptomics of blood and sputum eosinophils to identify pathogenic subsets and relate these to clinical outcomes. Aim 3: Define airway and systemic autoimmune signatures and integrate these with eosinophil states. Impact: This project will identify distinct eosinophil subsets and biomarkers to enable precision medicine in severe asthma and improve understanding of treatment failure.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ruzic, Alexander
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~